S. Patrick

发表

RPA phosphorylation in mitosis alters DNA binding and protein-protein interactions.

J. Turchi, G. Oakley, S. Patrick, 2003, Biochemistry.

Targeting the nucleotide excision repair pathway for therapeutic applications

J. Turchi, S. Patrick, 2012 .

Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.

S. Patrick, Sanjeevani Arora, Anbarasi Kothandapani, 2010, DNA repair.

Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.

D. Reisman, S. Patrick, Anbarasi Kothandapani, 2012, Experimental cell research.

Xeroderma Pigmentosum Complementation Group A Protein (XPA) Modulates RPA-DNA Interactions via Enhanced Complex Stability and Inhibition of Strand Separation Activity*

J. Turchi, S. Patrick, 2002, The Journal of Biological Chemistry.

Stopped-flow Kinetic Analysis of Replication Protein A-binding DNA

J. Turchi, S. Patrick, 2001, The Journal of Biological Chemistry.

DNA damage induced hyperphosphorylation of replication protein A. 2. Characterization of DNA binding activity, protein interactions, and activity in DNA replication and repair.

J. Turchi, G. Oakley, S. Patrick, 2005, Biochemistry.

Interactions of mammalian proteins with cisplatin-damaged DNA.

J. Turchi, S. Patrick, K. Henkels, 1999, Journal of inorganic biochemistry.

Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells

H. Zhang, G. Bepler, S. Patrick, 2016, Oncotarget.

DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair

Y. Zou, S. Patrick, P. Musich, 2012, Oncogene.

Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance

Gen Sheng Wu, M. Shekhar, Junhao Zhou, 2022, Frontiers in Oncology.

Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells

Q. Dou, S. Patrick, P. Erhardt, 2018, Nutrients.

Physical interaction between replication protein A (RPA) and MRN: involvement of RPA2 phosphorylation and the N-terminus of RPA1.

G. Oakley, S. Patrick, Kristin Tillison, 2009, Biochemistry.

DNA damage induced hyperphosphorylation of replication protein A. 1. Identification of novel sites of phosphorylation in response to DNA damage.

J. Turchi, G. Oakley, S. Patrick, 2005, Biochemistry.

Replication Protein A (RPA) Binding to Duplex Cisplatin-damaged DNA Is Mediated through the Generation of Single-stranded DNA*

J. Turchi, S. Patrick, 1999, The Journal of Biological Chemistry.

High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.

J. Turchi, S. Patrick, K. Henkels, 1997, Biochimica et biophysica acta.

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.

J. Turchi, S. Chaney, S. Patrick, 1999, Biochemistry.

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53

G. Bepler, Chuangui Wang, Shengyan Xiang, 2020, Cell Death & Disease.

Differential role of base excision repair proteins in mediating cisplatin cytotoxicity.

S. Patrick, Akshada Sawant, R. Sobol, 2017, DNA repair.

Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.

S. Patrick, Akshada Sawant, Anbarasi Kothandapani, 2015, DNA repair.

Behavior of T7 RNA Polymerase and Mammalian RNA Polymerase II at Site-specific Cisplatin Adducts in the Template DNA*

P. Hanawalt, S. Tornaletti, J. Turchi, 2003, Journal of Biological Chemistry.

Replication protein A: directing traffic at the intersection of replication and repair.

G. Oakley, S. Patrick, 2010, Frontiers in bioscience.

Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity*

S. Patrick, Anbarasi Kothandapani, Xiao-hong Wang, 2011, The Journal of Biological Chemistry.

Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer

G. Bepler, A. Schwartz, S. Patrick, 2018, Clinical Cancer Research.

Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition.

S. Patrick, S. Kaliyaperumal, K. Williams, 2011, Mutation research.

Prolonged cell cycle response of HeLa cells to low-level alkylation exposure.

S. Patrick, A. Schroering, Anbarasi Kothandapani, 2009, Cancer research.

Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy

S. Patrick, O. Merkel, Daniel P Feldmann, 2020, Molecules.

Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling

S. Patrick, R. Ruch, Joshua R. Heyza, 2018, Cancers.

APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response

A. Bhagwat, S. Patrick, Akshada Sawant, 2020, NAR cancer.

Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.

J. Turchi, S. Patrick, K. Henkels, 1997, Biochemistry.

HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.

J. Ruterbusch, S. Patrick, M. Cote, 2020, DNA repair.

Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks

Jay Z. Parrish, David J. Chen, J. Parrish, 2005, EMBO reports.

Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity

S. Patrick, Akshada Sawant, Anbarasi Kothandapani, 2013, Nucleic acids research.

In Vivo Targeting Replication Protein A for Cancer Therapy

Navnath S. Gavande, S. Jalal, J. Turchi, 2022, Frontiers in Oncology.

Chemical exhaustion of RPA in cancer treatment

Navnath S. Gavande, S. Jalal, J. Turchi, 2020, bioRxiv.

Partial Reconstitution of Human DNA Mismatch Repair In Vitro: Characterization of the Role of Human Replication Protein A

Liya Gu, J. Turchi, S. Patrick, 2002, Molecular and Cellular Biology.

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

G. Bepler, J. Turchi, A. Schwartz, 2023, NAR cancer.

Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.

J. Turchi, S. Patrick, 1998, Biochemistry.

Evidence for base excision repair processing of DNA interstrand crosslinks.

S. Patrick, Anbarasi Kothandapani, 2013, Mutation research.

Recognition of cisplatin-DNA interstrand cross-links by replication protein A.

S. Patrick, Kristin Tillison, J. Horn, 2008, Biochemistry.